Declines in contraceptive visits in the United States during the COVID-19 pandemic.

Autor: Steenland MW; Population Studies and Training Center, Brown University, Providence, RI, United States. Electronic address: maria_steenland@brown.edu., Geiger CK; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, MA, United States., Chen L; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, MA, United States., Rokicki S; Department of Health Behavior, Society, & Policy, Rutgers School of Public Health, Piscataway, NJ, United States., Gourevitch RA; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, MA, United States., Sinaiko AD; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, United States., Cohen JL; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Jazyk: angličtina
Zdroj: Contraception [Contraception] 2021 Dec; Vol. 104 (6), pp. 593-599. Date of Electronic Publication: 2021 Aug 14.
DOI: 10.1016/j.contraception.2021.08.003
Abstrakt: Objective: To document the change in contraceptive visits in the United States during the COVID-19 pandemic.
Study Design: Using a nationwide sample of claims we analyzed the immediate and sustained changes in contraceptive visits during the pandemic by calculating the percentage change in number of visits between May 2019 and April 2020 and between December 2019 and December 2020, respectively. We examined these changes by contraceptive method, region, age, and use of telehealth, and separately for postpartum individuals.
Results: Relative to May 2019, in April 2020, visits for tubal ligation declined by 65% (95% CI, -65.5, -64.1), LARCs by 46% (95% CI, -47.0, -45.6), pill, patch, or ring by 45% (95% CI, -45.8, -44.5), and injectables by 16% (95% CI -17.2, -15.4). The sustained change in visits in December 2020 was larger for tubal ligation (-18%, 95% CI, -19.1, -16.8) and injectable (-11%, 95% CI, -11.4, -9.6) visits than for LARC (-6%, 95% CI, -6.6, -4.4) and pill, patch, and ring (-5%, 95% CI, -5.7, -3.7) visits. The immediate decline was highest in the Northeast and Midwest regions. Declines among postpartum individuals were smaller but still substantial.
Conclusions: There were large declines in contraceptive visits at the start of the COVID-19 pandemic and visit numbers remained below pre-pandemic levels through the end of 2020.
Implications: Declines in contraceptive visits during the pandemic suggest that many people faced difficulties accessing this essential health service during the COVID-19 pandemic.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: